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ABSTRACT Several studies have demonstrated that lipoplexes are two-phase systems over most mixing lipid/DNA charge
ratios. Because these studies have focused on small unilamellar vesicles (SUV), they leave open the question as to whether
a similar pattern is followed by other liposome types. The main purpose of this work is to examine the question further by
characterizing the assembly of cationic lipoplexes prepared from 1-[2-(oleoyloxy)ethyl]-2-oleyl-3-(2-hydroxyethyl)imidazolinium
chloride (DOTIM)/dioleoylphosphatidylethanolamine (DOPE) (1:1) liposomes of various types. Sedimentation in sucrose
density gradients reveals that large unilamellar vesicles (LUV) and sedimented multilamellar vesicles (sMLV), as opposed to
SUV, form lipoplexes that exist as a single phase over a relatively broad range of mixing (1/) ratios. This is indicated by
observing that most of the LUV and sMLV become involved in the assembly reaction up to mixing (1/) ratios of 4 and 9,
respectively, while only a small and constant fraction of SUV associates with DNA at all mixing (1/) ratios tested.
Consequently, while maximal (1/) ratios of ;4.5 and 9 are found in LUV and sMLV lipoplexes, respectively, a ﬁnal (1/) ratio
of only ;2 is determined in SUV lipoplexes. Isothermal titration calorimetry shows that this is the lowest possible charge ratio
achieved when liposomes are titrated with DNA. Based on these observations and on the size differences of the liposomes
used, a model of lipoplex formation is proposed.
INTRODUCTION
Cationic lipid-DNA complexes, also known as lipoplexes
(Felgner et al., 1997), have attracted much attention in recent
years for their potential use in gene therapy. The absence of
risk for infection, low immunogenicity, as well as ease of
manufacturing and broad applicability makes lipoplexes
a promising alternative to viral vectors. Currently, despite the
large amount of research in lipoplex mediated gene trans-
fection, the efﬁciency of these gene delivery systems is still
lower than desirable.
A starting point to develop more efﬁcient lipoplexes may
be to acquire fundamental knowledge on lipoplex formation.
Among the variety of physical interactions involved,
electrostatic interactions are one of the most relevant. The
concomitant release of condensed counterions into bulk
solution, a phenomenon extensively studied in the context of
other biomolecular association reactions (deHaseth et al.,
1977; Mascotti and Lohman, 1990), has been experimentally
observed upon lipoplex formation (Wagner et al., 2000;
Simberg et al., 2001). The subsequent increase in entropy
represents the major driving force for this reaction
(Bruinsma, 1998; Harries et al., 1998), as it compensates
for the positive enthalpy changes typically observed when
pure cationic lipids interact with DNA (Spink and Chaires,
1997; Kennedy et al., 2000; Matulis et al., 2002; Pozharski
and MacDonald, 2002).
DNA condensation and liposome restructuring are known
to occur during lipoplex formation. Liposome restructuring
involves both liposome fusion (Gershon et al., 1993; Mok
and Cullis, 1997) and release of the vesicle aqueous contents
(Kikuchi and Carmona-Ribeiro, 2000; Kennedy et al., 2000).
Further evidence for liposome restructuring is provided from
electron microscopy, which shows elongated rod-like
structures (Gershon et al., 1993) and aggregates of globular
particles (Sternberg et al., 1994; Mok and Cullis, 1997;
Eastman et al., 1997). Cryoelectron microscopy (Gustafsson
et al., 1995; Lasic et al., 1997; Huebner et al., 1999; Schmutz
et al., 1999) and small angle x-ray scattering studies of such
aggregates (Lasic et al., 1997; Ra¨dler et al., 1997;
Boukhnikachvili et al., 1997) reveal an internal multilamellar
structure, where lipid bilayers alternate with hydrated DNA
monolayers. This lamellar structure coexists with an inverted
hexagonal structure when the cationic liposomes contain
dioleoylphosphatidylethanolamine (DOPE) at molar ratios
greater than 0.41 (Koltover et al., 1998; Lin et al., 2000).
Lipoplexes prepared from small unilamellar vesicles
(SUV) are commonly found in coexistence with a sec-
ond phase, either cationic liposomes or DNA, depending
on whether their preparation takes place above or below a
(1/) ratio of 1, respectively (Ra¨dler et al., 1997, 1998;
Xu et al., 1999). Separation of the excess component by
sedimentation in sucrose density gradients followed by
analysis of the lipid and DNA content of the puriﬁed
lipoplexes shows that the ﬁnal lipid/DNA ratios are constant
in each regime, with (1/) ratios of ;0.5 and 3 for
lipoplexes prepared below and above a (1/) ratio of 1,
respectively (Xu et al., 1999).
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Similarly to the study of Xu and co-workers, this work
characterizes lipoplex formation by determining the ﬁnal
lipid/DNA ratios of lipoplexes. Focusing on the excess
cationic lipid regime, the main question addressed here is
whether the type of liposomes used in lipoplex formation
affects the fraction of lipid that binds to DNA. We were
prompted to pursue this question because of an electron
microscopy study done by our group showing a larger
fraction of DNA-free liposomes when SUV are used to
complex DNA instead of sedimented multilamellar vesicles
(sMLV) (Jang and Heath, 1997). Additional motivation for
this study came from the lack of characterization studies
using MLV lipoplexes, and from the well established
knowledge that these are better transfecting agents than
SUV lipoplexes (Felgner et al., 1994; Liu et al., 1997; Ross
et al., 1998; MacDonald et al., 1999; Ross and Hui, 1999;
Zuidam et al., 1999), thus making their characterization an
essential step toward the development of more efﬁcient gene
delivery systems.
Using three types of 1-[2-(oleoyloxy)ethyl]-2-oleyl-3-(2-
hydroxyethyl)imidazolinium chloride (DOTIM)/DOPE (1:1)
liposomes, with diameters varying from 25 nm up to[1 mm,
and a 7.2-kb plasmid, we present an extensive characteriza-
tion of the effect of liposome type on lipoplex formation.
In addition to the sedimentation studies, the association
reaction is also characterized using isothermal titration





DOPE and N-(lissamine rhodamine B sulfonyl)phosphatidylethanolamine
(N-Rh-PE) were obtained from Avanti Polar Lipids (Alabaster, AL). The
cationic lipid DOTIM was synthesized as previously described (Solodin
et al., 1995). All lipids were dissolved in chloroform and stored under argon
at208C. Sodium deoxycholate and Hepes were purchased from Sigma (St.
Louis, MO) and sucrose was obtained from Mallinckrodt (St. Louis, MO).
Glucose was from Fisher Scientiﬁc (Fair Lawn, NJ).
Plasmid DNA
p4241, a 7.2-kb plasmid expressing the luciferase gene, was isolated and
puriﬁed as previously described (Liu et al., 1997). DNA concentration in the
stock solutions was determined spectroscopically assuming an absorbance
of 1 at 260 nm for a 50-mg/ml solution (0.15 mM DNA phosphate). The
A260/A280 was always between 1.8 and 1.9, indicating that there was no
protein or RNA contamination.
Liposome and lipoplex preparation
MLV were prepared from 49.75:49.75:0.5 DOTIM/DOPE/N-Rh-PE in
a screw-capped glass tube, protected from light. Chloroform was removed in
a rotary evaporator, and the thin lipid ﬁlm was then exposed to a vacuum
overnight. The lipids were resuspended in nonionic aqueous media (water or
5% w/v glucose), with gentle vortex mixing, and further incubated at 458C,
for ;6 h, to give a milky suspension of MLV. SUV were produced
by sonication of MLV, usually for 20 min, in a cylindrical sonic bath
(Laboratory Supplies, Hicksville, NY) until a translucent lipid suspension
was obtained. Large unilamellar vesicles (LUV) were prepared by extrusion
of MLV suspensions in an extruder (Lipex Biomembranes, Vancouver,
Canada) attached to an argon cylinder. The MLV were extruded six times at
moderate pressure (\2000 kPa) through two stacked 13-mm polycarbonate
membranes with pore diameters of 50 nm, 100 nm, or 200 nm, depending on
the intended vesicle size. Sedimentation of an aqueous suspension of MLV
at 85,000 3 g for 45 min at 108C, in a Beckman L8-60M Ultracentrifuge
equipped with a SW 55Ti rotor (Beckman Coulter, Fullerton, CA) produced
a thick pellet of sMLV, which was resuspended in water after carefully
removing the supernatant. The DOTIM concentration in the liposome
suspensions was typically 10 mM, and was measured from the absorbance at
238 nm, using a molar extinction coefﬁcient for DOTIM of 6809.2
M1cm1.
Stock suspensions of liposomes and DNA were diluted in Hepes buffer
(Hepes 10 mM, NaCl 10 mM, pH 7.4) before lipoplex formation, which was
achieved by adding 1 vol diluted plasmid DNA to 3 vol diluted liposome
suspension (SUV, LUV, or sMLV), with gentle mixing. The ﬁnal
concentration of DOTIM in the lipoplexes was usually 0.625 mM and the
DNA concentration varied between 62.5 and 25 mg/ml depending on the
mixing (1/) ratios. DOTIM and DNA content of lipoplexes was checked
after their formation using the quantiﬁcation procedures described below.
Transmission electron microscopy
Samples were prepared for transmission electron microscopy by negative
staining with uranyl acetate using a two-step method. A drop of liposome
suspension was ﬁrst applied onto a pioloform (Ted Pella, Redding, CA)
coated 400 mesh Ni thin bar grid, allowed to adsorb for 1 min, and then
blotted with ﬁlter paper. After air-drying for 3 min, a drop of 2% aqueous
uranyl acetate stain was applied to the prepared sample grid and immediately
blotted with ﬁlter paper. In the case of sMLV, resolution was improved with
ﬁxation by combining and vortexing (10 s) the sMLV suspension with an
equal volume of 1% osmium tetroxide. Total osmium tetroxide ﬁxation time
was 1 min at room temperature. Then, the osmium/sample solution was
placed on the pioloform grid and stained with uranyl acetate as described
above. After the negatively stained samples air-dried for 3 min, they were
examined on a Philips CM120 TEM at 80 kV (Philips Electron Optics,
Eindhoven, The Netherlands).
Dynamic light scattering
Particle size was measured at 208C, in a Nicomp 380 ZLS dynamic light
scattering instrument (Nicomp Particle Sizing Systems, Santa Barbara, CA),
equipped with a 30-mW laser (632.8-nm wavelength) and an Avalanche
photodiode detector. The scattered light intensity detected at a 908 angle was
treated using the Gaussian or multimodal Nicomp analysis, depending on the
polydispersity of the samples, and the data presented corresponds to the
volume weighted distributions. The mean diameters shown are averages of
3–6 measurements performed on different samples for periods of time long
enough (from 15 min to 24 h) to collect statistically reliable data.
Discontinuous sucrose density gradients
After 30-min incubation the lipoplexes were characterized by sedimentation
to equilibrium in discontinuous sucrose density gradients. The gradients
were prepared in 13-3 51-mm Ultra-Clear centrifuge tubes by successively
layering 2 ml 20%, 1 ml 10%, and 1 ml 5% w/v sucrose. The lipoplex
suspension was then loaded on the top of the gradient and sedimented at
116,000 3 g for 16 h at 108C, in a Beckman L8-60M Ultracentrifuge,
equipped with a SW 55Ti rotor (Beckman Coulter). Gradients were
fractionated after sedimentation based on the position of the lipoplex bands.
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The position of each fraction in the gradient was expressed by determining
its cumulative volume, calculated by adding half the fraction volume to the
volume of any fractions located above it. Each fraction was assayed for both
DOTIM and DNA content using the procedures described below.
DOTIM and DNA quantiﬁcation
The DOTIM concentration was determined after sodium deoxycholate (12
mM) solubilization of the complexes by measurement of N-Rh-PE
ﬂuorescence intensity at 590 nm, with an excitation wavelength of 550
nm (slit widths of 5 nm), in a Hitachi F-3010 ﬂuorescence spectrophotom-
eter (Hitachi Instruments, San Jose, CA). The DNA concentration in each
fraction was determined both by UV spectroscopy and ﬂuorimetry. In the
UV spectroscopic assay, the material present in each fraction was solubilized
in sodium deoxycholate (12 mM), and the absorbance at 275 nm was
measured using a Hitachi-3000 UV/VIS spectrophotometer (Hitachi Instru-
ments). Owing to the absorbance of DOTIM and N-Rh-PE at 275 nm, it was
necessary to correct the DNA absorbance readings of the complexes by ﬁrst
subtracting the contribution of these two components for the absorbance
reading. The contribution of DOTIM and N-Rh-PE to the absorbance was
determined by using a standard curve where ﬂuorescence intensities of
N-Rh-PE at 590 nm were correlated to the absorbance of both components
at 275 nm. After this correction, DNA concentration was calculated using
a DNA standard curve. In the ﬂuorimetric assay, lipoplexes were extracted
with chloroform and methanol (Bligh and Dyer, 1959) to remove lipid,
Hoechst dye ([Hoechst] ¼ 0.4 mg/ml) was added to the aqueous phase, and
the ﬂuorescence signal of the DNA-Hoechst dye complex was followed at
465 nm, with excitation at 350 nm (slit widths of 5 nm), using the
ﬂuorescence spectrophotometer mentioned above. No DNA was detected in
the chloroform phase of the extraction. The ﬁnal DNA concentrations were
calculated from a standard curve obtained after chloroform/methanol
extraction of DNA standard solutions.
Isothermal titration calorimetry
The enthalpy change associated with the interaction between DOTIM/DOPE
(1:1) liposomes and plasmid DNA was measured using an isothermal
titration calorimeter (MicroCal, Northampton, MA) at 258C. Before the
measurements, both plasmid DNA (7.2 kb) and liposomes (SUV or sMLV)
were extensively dialyzed against Hepes buffer (10 mM Hepes, 10 mM
NaCl, pH 7.4) and degassed for 15 min. Approximately 1.7 ml of a sample
consisting of DOTIM/DOPE (1:1) liposomes was loaded into the sample cell
(vol ¼ 1.338 ml) and 10-ml aliquots of DNA solution were injected into the
cell using the automated 250-ml rotating stirrer-syringe at constant time
intervals of 6 min. Similar results were obtained using concentrations of 0.4
mM DOTIM and 3 mM DNA phosphate groups or 0.2 mM DOTIM and 1.5
mM DNA, respectively. A control titration, in which DNA was added to
pure buffer, was used to correct the enthalpy of each injection for the heat of
DNA dilution. Raw data were processed using Origin graphing software
provided with the instrument.
RESULTS
Particle size analysis of liposomes
Table 1 shows the mean diameters of DOTIM/DOPE (1:1)
liposomes. SUV have a mean volume-weighted diameter of
47.2 nm, whereas for sMLV the value is 850 nm. Particle
size distributions (Fig. 1 c) show SUV and sMLV to be
polydisperse. For the SUV, the majority of vesicles are 25
nm in diameter, with a smaller fraction of vesicles close to
100 nm, whereas for the sMLV most vesicles are close to
1 mm in diameter, with a smaller fraction of vesicles in the
300-nm range. These size measurements were conﬁrmed by
negative staining transmission electron microscopy, which
shows a large fraction of SUV 25–30 nm in diameter (Fig.
1 a), whereas sMLV suspensions contain vesicles whose
diameters vary from 500 nm to almost 2 mm (Fig. 1 b). LUV
extruded to 50, 100, and 200 nm have mean diameters of
75.9, 127.7, and 180.0 nm, respectively (Table 1). Of the
three LUV preparations, the 50-nm extruded vesicles are the
most homogeneous, as indicated by the narrower peak
distributions (Fig. 1 d).
Final lipid/DNA ratios of sedimented lipoplexes
SUV and sMLV
Fig. 2 shows the discontinuous sucrose density gradients
obtained with DOTIM/DOPE (1:1) SUV and sMLV lipo-
plexes prepared at a (1/) ratio of 3.6. The SUV gradient
contains a translucent band on the top, and a denser, more
turbid band, located at the interface between the 10 and 20%
w/v sucrose layers. The sMLV lipoplex gradient shows no
evidence of a lipid band on the top, and contains one band at
the interface of the 10 and 20%w/v sucrose layers, and amore
diffuse band within the 10% w/v sucrose layer. Therefore, as
shown in earlier microscopy studies (Jang and Heath, 1997),
these results point to the existence of a larger amount of free
liposomes in DOTIM/DOPE (1:1) SUV lipoplex suspensions
as compared to sMLV lipoplexes. Quantiﬁcation of DOTIM
and DNA in the gradient fractions, shown in Table 2,
conﬁrmed this observation. Approximately one third of the
DOTIM in SUV lipoplexes is located in fractions 1 and 2,
whereas only 5.5% of the DOTIM is found at a similar
position (fraction 1) for sMLV lipoplexes. The negligible
amounts of DNA found in these fractions for both lipoplex
types conﬁrm that this lipid corresponds to free liposomes.
Most of the DNA (;73%) in SUV lipoplexes is detected in
fraction 4, whereas for sMLV lipoplexes the DNA distributes
mainly between fractions 3 and 4, most being found in the
lower density fraction 3. The difference between SUV and
sMLV lipoplexes described above is accurately reﬂected in
the weighted average ﬁnal (1/) ratios, which we have
calculated for all fractions containing signiﬁcant amounts of
TABLE 1 Characterization of DOTIM/DOPE (1:1) liposomes
using dynamic light scattering
Liposome type Mean diameter 6 SD, nm
SUV 47.2 6 32.4
LUV 50 75.9 6 25.5
LUV 100 127.7 6 88.6
LUV 200 180.0 6 98.3
sMLV 854 6 390
The mean diameters and standard deviations (SD) of the particle size
distributions shown are averages of 3–6 measurements performed on
different liposome preparations for periods of time ranging from 15 min up
to 24 h.
1556 Goncxalves et al.
Biophysical Journal 86(3) 1554–1563
both lipid and DNA (3 and 4 for SUV and 2–4 for sMLV
lipoplexes). This value is 3.4 for sMLV lipoplexes, but only
2.1 for SUV lipoplexes. The weighted average ﬁnal (1/)
ratios are used in the studies described below.
Fig. 3 shows the DOTIM and DNA sedimentation proﬁles
of lipoplexes prepared from DOTIM/DOPE (1:1) SUV and
sMLV at various mixing (1/) ratios. For the SUV
lipoplexes, the distribution proﬁles are similar for all mixing
ratios used, with a major fraction of DNA and some DOTIM
sedimenting to;2.5 ml from the top of the gradient. There is
also an increasing accumulation of DOTIM in the ﬁrst two
gradient fractions as the mixing (1/) ratios are increased.
This lipid is identiﬁed as DNA-free liposomes, not only
because SUV tend to accumulate at this position when
sedimented in the absence of DNA (SUV curve), but also
because insigniﬁcant amounts of DNA are found in these
fractions at all mixing (1/) ratios.
For sMLV lipoplexes, both DOTIM and DNA accumulate
at ;1.6 ml from the gradient top for lower mixing (1/)
ratios (#4.2), but are progressively displaced to ;0.7 ml
from the gradient top at higher mixing (1/) ratios. The
amount of lipid retained in the ﬁrst gradient fraction
increases slightly upon increase of the mixing (1/) ratios.
sMLV sedimented in the absence of DNA (sMLV curve) are
also found in fraction 1, conﬁrming that the lipid retained in
this fraction corresponds to DNA-free liposomes.
The ﬁnal (1/) ratios are plotted as a function of the
mixing (1/) ratios in Fig. 4. Lipoplexes made from SUV
show a constant ﬁnal (1/) ratio of ;2, regardless of the
mixing ratios used in lipoplex formation. In contrast, sMLV
form lipoplexes whose ﬁnal (1/) ratios increase in direct
proportion to the initial mixing (1/) ratios, showing an
almost quantitative incorporation of the cationic lipid into the
lipoplexes.
LUV
Fig. 5 shows the DOTIM and DNA sedimentation proﬁles
obtained for lipoplexes prepared from three different LUV
FIGURE 1 Particle size of liposomes. (a and
b) Transmission electron micrographs of DO-
TIM/DOPE (1:1) SUV (a) and sMLV (b)
obtained after negative staining with uranyl
acetate. The sMLV samples were ﬁxed with
osmium tetroxide before staining with uranyl
acetate. (c) Volume-weighted Nicomp (multi-
modal) particle size distributions from dynamic
light scattering of DOTIM/DOPE (1:1) SUV
(solid line) and sMLV (dashed line). (d)
Volume-weighted Gaussian particle size distri-
butions of LUV extruded through polycarbonate
membranes with pore diameters of 50 (solid
line), 100 (dashed line), or 200 nm (dotted line).
FIGURE 2 Sedimentation of DOTIM/DOPE (1:1) lipoplexes in discon-
tinuous sucrose density gradients. Cationic lipoplexes were prepared from
either SUV or sMLV at a (1/) ratio of 3.6 and sedimented at 116,0003 g
for 16 h, at 108C, in discontinuous sucrose density gradients.
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preparations described above (Table 1; Fig. 1). LUV
lipoplexes sediment to ;2 ml from the gradient top at the
lowest mixing (1/) ratios, and are progressively displaced
toward lower density positions at higher mixing (1/)
ratios. The ﬁnal (1/) ratios obtained from these studies are
plotted against the mixing (1/) ratios in Fig. 6. All three
LUV preparations form lipoplexes for which the ﬁnal (1/)
ratio appears to approach a maximum of 4.5–5, and is close
to the mixing ratio for (1/) ratios below;4. No signiﬁcant
differences in the ﬁnal (1/) ratios are observed among the
three types of LUV lipoplexes.
Particle size analysis of sedimented lipoplexes
Fig. 7 shows the particle size for a series of SUV and sMLV
lipoplex preparations sedimented in sucrose density gra-
dients. The results shown are the mean volume-weighted
diameters of the lipoplexes isolated in fraction 4 for SUV
TABLE 2 Composition of lipoplexes prepared from DOTIM/DOPE (1:1) liposomes after sedimentation in sucrose density gradients
Mixing ratio Cumulative
DOTIM DNA
Lipoplex (1/) Fraction volume, ml % of total Final ratio* (1/)
SUV 3.6 6 0.2 1 0.13 6 0.02 16.3 6 1.8 0.9 6 0.3 2.1 6 0.08
2 0.42 6 0.03 15.2 6 0.8 1.4 6 0.3
3 1.35 6 0.03 11.8 6 3.3 16.7 6 4.1
4 2.45 6 0.08 41.0 6 2.8 72.6 6 1.5
sMLV 3.8 6 0.5 1 0.15 6 0.01 5.5 6 0.8 1.2 6 0.2 3.4 6 0.33
2 0.69 6 0.02 11.8 6 4.4 5.3 6 2.4
3 1.55 6 0.03 45.5 6 5.7 49.9 6 5.0
4 2.32 6 0.07 20.1 6 2.1 31.7 6 4.7
Cationic lipoplexes were prepared from either SUV or sMLV at the (1/) ratios indicated in the table, and sedimented at 116,000 3 g for 16 h, at 108C.
After sedimentation, the gradient was fractionated by collecting fractions from the top of the tubes, and the volume of each fraction was recorded. DOTIM
and DNA content was determined in each fraction as described under Materials and Methods. Results are mean values of three determinations 6 standard
deviations. The total recovery of DOTIM and DNA in all the fractions was usually[85%.
*(1/) ratios were calculated taking into consideration that 1 nmol DOTIM contains 1 nmol positive charge and 1 mg DNA is 3 nmol negatively charged
phosphate.
FIGURE 3 DOTIM and DNA sedimentation
proﬁles of lipoplexes prepared from a 7.2-kb
plasmid and DOTIM/DOPE (1:1) SUV or
sMLV. The results shown are the amounts of
DOTIM and DNA detected in each fraction
collected from the gradient. The cumulative
volume indicates the position of each fraction
in the gradient, and the mixing (1/) ratio
used in lipoplex formation is indicated in the
legends. The SUV and sMLV curves corre-
spond to the sedimentation of DNA-free
liposomes.
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lipoplexes, and in fraction 3 for sMLV lipoplexes.
Sedimented SUV lipoplexes have a mean diameter of
201.2 nm at a mixing (1/) ratio of 2.7, which is ;8 times
larger than the original size of most SUV (Fig. 1). The
limited reduction in lipoplex size observed upon increase of
the mixing (1/) ratios suggests that SUV lipoplexes are
constant in size. sMLV lipoplexes have a mean diameter of
;850 nm for the range of mixing (1/) ratios tested, which
is similar to the mean diameter found in the DNA-free sMLV
(Table 1). A small decrease in lipoplex size is observed upon
increase of the mixing (1/) ratios.
Enthalpy changes associated with DOTIM/DOPE
(1:1) liposome-DNA interactions
The association reaction between DOTIM/DOPE (1:1)
liposomes and DNA was characterized by isothermal
titration calorimetry. Fig. 8 a shows typical calorimetric
traces obtained after addition of successive amounts of DNA
to buffer, SUV, or sMLV, and Fig. 8 b represents the
cumulative heat curves plotted against the (/1) ratios for
each liposome type. The enthalpy change detected upon
interaction between DOTIM/DOPE (1:1) liposomes and
DNA is negative, revealing that lipoplex formation occurs
through an exothermic reaction. The endpoints of the SUV
and sMLV titrations are separated by only one DNA in-
jection, showing that the reaction progresses to the same
extent for both liposome types. The endpoints occur at (/1)
ratios of 0.5 for SUV and 0.45 for sMLV, which correspond
to (1/) ratios of 2.0 and 2.2 for SUV and sMLV,
respectively.
FIGURE 4 Final (1/) ratios in lipoplexes prepared from a 7.2-kb
plasmid and DOTIM/DOPE (1:1) SUV or sMLV. Cationic lipoplexes were
prepared from each liposome type at various (1/) ratios and sedimented in
discontinuous sucrose density gradients. The ﬁnal (1/) ratios were
calculated from the DNA and DOTIM content of fractions 3 and 4 for SUV
lipoplexes, and fractions 2, 3, and 4 for sMLV lipoplexes. There are 4–6
replicates in each point.
FIGURE 5 DOTIM and DNA sedimentation proﬁles of lipoplexes prepared from a 7.2-kb plasmid and DOTIM/DOPE (1:1) LUV extruded through
membranes with pore diameters of 50 (LUV 50), 100 (LUV 100), and 200 nm (LUV 200). The numbers in the legends indicate the (1/) ratios used in
lipoplex formation. The LUV curves (LUV 50, 100, and 200) correspond to the sedimentation of DNA-free LUV.
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DISCUSSION
The most striking observation made in this study is that
lipoplexes can exist as single-phase systems over a much
broader range of mixing lipid/DNA ratios than previously
reported. Focusing on the excess cationic lipid regime, we
show that this is the case with sMLV and the three LUV
lipoplex preparations analyzed. This conclusion is based on
the relatively small amounts of DNA-free liposomes found
in sMLV lipoplexes up to mixing (1/) ratios close to 9
(Fig. 3), and by observing a similar trend in LUV lipoplexes
prepared at (1/) ratios below ;4 (Fig. 5). In agreement
with previous studies (Ra¨dler et al., 1997, 1998; Xu et al.,
1999), and contrasting with the other two lipoplex types,
SUV lipoplexes coexist with a signiﬁcant excess of
liposomes at most of the mixing (1/) ratios tested (Fig.
3). Stating the situation differently, signiﬁcantly higher ﬁnal
(1/) ratios may be achieved when lipoplexes are prepared
from larger liposomes. This is clearly illustrated by
comparing the (1/) ratio of ;2 found in the isolated
SUV lipoplexes (Fig. 4) with the maximal values of ;4.5
and 9 found in the LUV (Fig. 6) and sMLV lipoplexes (Fig.
4), respectively. Because sMLV do not appear to reach
a saturating ﬁnal (1/) ratio within the range of mixing
ratios tested (Fig. 4), it is possible that a bigger difference
separates sMLV from the other two types of lipoplexes.
MLV lipoplexes are generally better transfecting agents
than SUV lipoplexes (Felgner et al., 1994; Liu et al., 1997;
Ross et al., 1998; MacDonald et al., 1999; Ross and Hui,
1999; Zuidam et al., 1999). The larger size of MLV
lipoplexes, often indicated as the main reason, might not
be the only factor involved, since these are still better
transfecting vectors than SUV lipoplexes of comparable size
(Ross and Hui, 1999). The absolute requirement of an excess
of cationic lipid for efﬁcient gene transfection (Barron et al.,
1999), suggests that the higher ﬁnal (1/) lipoplex ratios
achieved with larger liposomes may correlate in some way
with higher gene expression levels. This hypothesis is
currently under analysis.
The effect of liposome size on lipoplex formation is of
considerable signiﬁcance, and we may explain this effect by
constructing a model of what happens when DNA ﬁrst binds
to the liposomes during lipoplex formation (Fig. 9).
Theoretical estimates show that our dominant SUV pop-
ulation (25 nm in diameter) contains ;2000 cationic lipid
FIGURE 7 Mean particle size of SUV lipoplexes sedimented in fraction 4
and sMLV lipoplexes sedimented in fraction 3 as a function of the mixing
lipid/DNA ratios. The values shown are the volume-weighted mean
diameters of the Gaussian distributions.
FIGURE 6 Final (1/) ratios in lipoplexes prepared from a 7.2-kb
plasmid and DOTIM/DOPE (1:1) LUV obtained by extrusion through
polycarbonate membranes with pore diameters of 50 (LUV 50), 100 (LUV
100), and 200 nm (LUV 200). All fractions, except fraction one, were
considered in the calculation of the ﬁnal lipid/DNA ratios. There are 4–6
replicates in each point.
FIGURE 8 (a) Isothermal titration calorimetric traces and (b) cumulative
heats of reaction obtained after titration of DOTIM/DOPE (1:1) SUV or
sMLV (0.4 mM in DOTIM) with 10-ml aliquots of a 7.2-kb plasmid (3 mM),
at 258C. The heat of dilution was obtained by titrating DNA into pure buffer
(10 mM Hepes, 10 mM NaCl, pH 7.4). A quantity of 30 nmol DNA was
added in each injection, and the calorimeter cell contained a total of 535
nmol DOTIM.
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molecules per vesicle, as compared to 14,400 anionic
phosphate charges present in the 7.2-kb plasmid. (The
number of cationic lipid molecules in the lipid bilayer was
estimated assuming that liposomes are hollow spheres of the
indicated diameter (d), that the cross-sectional area of each
lipid molecule is 0.7 nm2, and that the bilayer is 4-nm thick.
The surface area of the internal and external monolayers was
calculated using the formula A ¼ 8p(0.25d2  2d 1 8), and
the value thereby obtained was divided by 2 3 0.7, to
account for the presence of 50 mol% neutral lipid (e.g.,
DOPE) in the vesicles.) Therefore, for SUV lipoplexes
prepared at an excess of cationic lipid, multiple liposomes
will initially associate with each 7.2-kb plasmid in solution
(Fig. 9 a). The association of SUV with DNA will occur only
until a slight excess of cationic lipid is incorporated into
the complexes. Subsequently, liposomes and DNA should
rearrange into a condensed phase as shown by others
(Gershon et al., 1993; Mok and Cullis, 1997), but
electrostatic repulsions should prevent further binding of
SUV to the positively charged complexes. Therefore, SUV
lipoplexes are predicted by our model, as observed here and
elsewhere, to have relatively constant and small ﬁnal (1/)
ratios (Fig. 4), and to coexist with an excess of cationic
liposomes at most mixing (1/) ratios above charge
neutrality (Fig. 3). The signiﬁcant increase in particle size
observed upon lipoplex formation (Fig. 7) is also in
agreement with the involvement of multiple SUV, suggest-
ing extensive liposome fusion, as shown by others (Gershon
et al., 1993; Mok and Cullis, 1997).
In regard to sMLV lipoplexes (Fig. 9 b), a very different
situation exists. A 900-nm unilamellar vesicle, the average
size of our sMLV, contains 3.6 3 106 cationic lipid
molecules, which is sufﬁcient to neutralize 250 molecules
of the 7.2-kb plasmid. There will be an average of ;23
plasmids present per sMLV at a mixing (1/) ratio of 10,
which is the highest ratio we have used. Since the number of
plasmids per liposome is inversely related to the mixing (1/
) ratio, 23 is the smallest number of plasmids per sMLV in
our studies. Therefore, all liposomes are certain to interact
with DNA, because there are at least 23 plasmids present
per liposome. Furthermore, the average number of DNA
molecules binding initially to each sMLV can change and,
therefore, will decrease upon increase of the mixing (1/)
ratio. As a consequence, and consistent with the data
presented here, sMLV lipoplexes should tend to exist as
single phase systems over a relatively large range of mixing
lipid/DNA ratios (Fig. 3) and to have ﬁnal (1/) ratios that
increase proportionally with the mixing (1/) ratios (Fig. 4).
Because multiple DNA copies bind to each liposome, our
model also predicts that the size of sMLV lipoplexes should
be comparable to that of the original liposomes, a fact that is
experimentally shown by dynamic light scattering (Fig. 7).
For LUV lipoplexes, the situation is intermediate between
that of sMLV and SUV lipoplexes (Fig. 9 c). LUV are
capable of binding more than one plasmid, and for the lowest
FIGURE 9 Schematic model of lipoplex formation when a 7.2-kb plasmid
is mixed with (a) SUV, (b) sMLV, and (c) LUV. The top panels represent the
liposome preparations (spheres) before adding the plasmid (wavy solid line),
and the bottom panels represent the lipoplexes formed at an excess of
cationic lipid. In each case, the mixing (1/) ratios increase from left to
right.
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mixing (1/) ratios, LUV will bind multiple plasmids
(bottom left panel). As the mixing (1/) ratio increases to
intermediate values, the number of plasmids per vesicle will
decline, but all vesicles will still bind DNA (bottom middle
panel). Therefore, to this point, LUV behave similarly to
sMLV. However, because LUV are much smaller than
sMLV, the number of plasmids per liposome will fall below
one within the range of mixing (1/) ratios we have used.
For those higher mixing (1/) ratios, some LUV will bind
a single plasmid, which will coexist with an excess of DNA-
free liposomes (bottom right panel). Whether the events that
occur subsequent to initial binding depicted here will involve
some or all of the DNA-free liposomes is unclear. However,
once the lipoplexes are assembled, they will carry a net
positive charge, and the unbound liposomes are expected to
be repelled from the cationic lipoplexes, and to coexist as
a second phase with the condensed lipoplexes. In the case of
100-nm LUV, this model accurately predicts the initial rise
of the ﬁnal (1/) ratio, and the subsequent approach toward
a constant ﬁnal (1/) ratio of ;4. However, the model also
predicts differences in the maximal ﬁnal (1/) ratios among
the three types of LUV, a fact that is not observed
experimentally (Fig. 6). This suggests that either the size
differences among those LUV are not sufﬁciently large to
result in a signiﬁcant difference in the point at which the
maximal (1/) ratios are achieved or that additional factors
may be involved in determining those maximal ratios.
Careful interpretation of our ITC experiments provides
a signiﬁcant conﬁrmation of several key aspects of the model
described above. In the case of SUV, the model suggests that
SUV lipoplexes will contain no more lipid than is necessary
to effect complete neutralization of the DNA. Therefore, the
maximal possible (1/) ratio should correspond to the
maximal capacity of the lipid for DNA binding. Revealed by
the end point of the ITC titration, this value is in excellent
agreement with the maximal possible ﬁnal (1/) ratio
obtained in the gradient studies. In the case of sMLV, the
model suggests that lipid excess to what is required to
neutralize DNA is trapped in sMLV lipoplexes owing to the
excess binding capacity of the liposomes at higher (1/)
ratios. However, the close dependence of mixing and ﬁnal
ratios suggests that such excess lipid is potentially available
to bind DNA if sufﬁcient DNA is added. ITC studies of
sMLV lipoplexes conﬁrm that this excess lipid is available to
bind further DNA, and that the inherent capacity of sMLV to
bind DNA is similar to that of SUV. This further agrees with
the model proposed above.
Similarly to other studies that used liposomes containing
DOPE in their composition (Lobo et al., 2001; Pozharski and
MacDonald, 2002), our ITC data show that DOTIM/DOPE
(1:1) interact with DNA through an exothermic reaction (Fig.
8). As shown by Lobo et al. (2001), this is related to the fact
that the DOPE amine groups exist in the unprotonated state
before DNA binding, a phenomenon that is caused by the
relatively high surface pH usually measured in cationic
liposomes (Zuidam and Barenholz, 1999), and to the
concomitant proton uptake upon lipoplex formation.
Finally, one question regarding sMLV concerns the extent
to which their lamellarity may be a factor in the observations
that are described here. Multilamellarity would reduce the
fraction of the lipid available on the outer surface of the
liposome population for initial binding of DNA, and this
might increase the (1/) ratio in the lipoplexes. In an
extreme case, the lamellarity might so limit the amount of
liposomal lipid available for DNA binding that lipoplexes
might coexist with a DNA excess in a region where the
mixing (1/) ratio is greater than 1. Our experiments do not
support this interpretation for several reasons. First, were this
correct, our gradient studies would have shown the presence
of lipoplexes with high ﬁnal (1/) ratios, even for low
mixing (1/) ratios, and a free DNA fraction. Second, our
ITC studies would have shown an endpoint for sMLV at
a mixing (1/) ratio that was much greater than that seen
with SUV. Therefore, it seems unlikely that lamellarity,
rather than liposome size, is a factor in the observations that
we have made. We have used cobalt quenching of N-Rh-PE
to determine lamellarity, and have found only a limited
lamellarity for sMLV (data not shown). Based on what is
known about the formation of charged liposomes in nonionic
media, it is likely that sMLV formed in 5% w/v glucose will
be multilamellar to only a limited extent.
In conclusion, the marked differences observed between
SUV and larger liposomes in the formation of lipoplexes
may be explained by a simple consideration of the effects of
liposome size on the capacity of each liposome for DNA
binding and the number of liposomes per mol of lipid. We
hope, in future studies, to examine this further and to explore
its effect on the efﬁciency of transfection.
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